Stock Market Update - January 13, 2026
Today's stock market saw some significant movers. Here's a breakdown of 5 stocks that caught our attention:
1. XAIR - Beyond Air, Inc.
Price: $2.19 | Change: +150.00% ($1.314)
XAIR just posted an eye-catching 150.00% gain! This impressive jump for Beyond Air, Inc. followed the announcement on January 13, 2026, that XTL Biopharmaceuticals Ltd. would acquire an 85% stake in Beyond Air's subsidiary, NeuroNOS Ltd.
NeuroNOS focuses on developing treatments for Autism Spectrum Disorder (ASD) and neuro-oncology, a crucial area with no FDA-approved disease-modifying therapies for autism. The deal sees Beyond Air receiving cash, potential milestone payments up to $32.5 million, and a 19.9% equity stake in XTL, allowing Beyond Air to refocus on its core respiratory treatments. This move highlights the significant potential in the rapidly expanding autism therapeutics market, addressing a critical unmet medical need.
2. THH - TryHard Holdings Limited
Price: $55.05 | Change: +138.31% ($31.95)
THH:NASDAQ absolutely soared, marking a stunning 138.31% gain on January 13, 2026. This dramatic surge was primarily driven by two strategic announcements from TryHard Holdings Limited that ignited strong investor confidence.
The biggest news was a binding collaboration agreement with Carnegie Hill Capital Partners to establish a new investment fund based in Hong Kong. This fund, targeting $10 million to $20 million, will focus on a wide array of opportunities within the global entertainment industry, from international music festivals and film production to digital media and music rights. This partnership is a significant move for TryHard, allowing them to expand their global investment footprint well beyond Japan.
Adding to the positive momentum, TryHard also announced a US$10.0 million share repurchase program. This signals management's strong belief in the company's long-term growth trajectory and robust financial health, as buying back shares often indicates that the company considers its stock a good value. These combined efforts highlight TryHard's ambition for global expansion and its commitment to delivering value to shareholders.
3. AHMA - Ambitions Enterprise Management Co. L.L.C
Price: $12.34 | Change: +133.71% ($7.06)
AHMA experienced a remarkable 133.71% surge, drawing significant investor attention around January 14, 2026. This impressive jump was primarily fueled by Ambitions Enterprise Management Co.'s announcement of robust financial results for the first half of 2025. The company reported a substantial 191% increase in net income, coupled with a solid 14% rise in revenue, demonstrating strong growth and improved operational efficiency.
What's particularly noteworthy about AHMA is its trajectory since going public in October 2025, with the stock nearly tripling its initial IPO price. This upward movement is further supported by analysts highlighting the company's strategic investments and strengthening presence within the UAE's expanding travel, leisure, and MICE sectors.
4. XTLB - XTL Biopharmaceuticals Ltd.
Price: $1.07 | Change: +56.66% ($0.387)
XTLB just shot up by an impressive 56.66%! This significant jump came around January 14, 2026, after XTL Biopharmaceuticals Ltd. announced a binding agreement to acquire 85% of NeuroNOS Ltd., a subsidiary of Beyond Air, Inc. This strategic move aims to position XTL as a key player in the rapidly growing market for autism therapeutics.
The acquisition involves XTL giving up 19.9% of its shares, a $1 million cash payment, and potential milestone payments up to $32.5 million. NeuroNOS is focused on developing pioneering treatments for Autism Spectrum Disorder (ASD) and neuro-oncology.
What makes this particularly interesting is that NeuroNOS holds two FDA Orphan Drug designations for Phelan-McDermid Syndrome (an autism-related rare genetic disorder) and Glioblastoma (a type of brain cancer). Plus, the company boasts a strong scientific team, including its founder and two Nobel Laureates in Chemistry, adding significant weight to XTL's entry into this specialized therapeutic area.
5. HUBC - HUB Cyber Security Ltd.
Price: $0.5363 | Change: +56.49% ($0.1936)
HUBC saw an impressive 56.49% gain, largely fueled by a significant executive appointment. Investors reacted positively to HUB Cyber Security Ltd.'s announcement of Limor Zur-Stoller as the new Chief Financial Officer, effective January 12, 2026. Zur-Stoller brings over two decades of senior financial leadership, including expertise in capital markets and M&A, which is expected to strengthen the company's financial governance and support strategic growth, particularly in regulated data and digital asset sectors.
This positive sentiment was reinforced by other recent developments. In late December 2025, HUB Cyber Security secured a $5 million contract with the Israeli Ministry of Interior. Adding to the confidence, the company's CEO and board members also made open-market share purchases in December, signaling strong insider belief in the company's prospects.
Collectively, these events paint a picture of strategic momentum, with a new financial leader and strong insider backing contributing to the upward movement in HUBC's stock price.
This analysis was generated using AI and real-time stock data. Always do your own research before making investment decisions.